abstract |
The present invention provides compounds of formula (I), useful as hepatitis C virus (HCV) NS5A inhibitors, methods of synthesis of such compounds, and inhibit HCV NS5A activity in cell-based systems, treat or prevent HCV infection, And / or to the use of such compounds to inhibit viral production. (I) |